NLRP3 and inflammatory bowel disease: In an IBD rat model, supplementation with food-derived oryzanol increased SCFAs levels in the gut, which inhibited the TLR4/NF-κB/NLRP3 pathway and reduced intestinal barrier damage and inflammation (Xia et al., 2022).